RecruitingNot ApplicableNCT06547684

Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients

Effects of Focused Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients: a Randomized Controlled Trial

Sponsor

Teresa Mateu Campos

Enrollment

60 participants

Start Date

Aug 28, 2020

Study Type

INTERVENTIONAL

Conditions

Stroke Spasticity, Muscle Equinus Deformity

Summary

The goal of this study is to evaluate long term effects of focused extracorporeal shock wave therapy (fESWT) on triceps surae spasticity in stroke patients according to the number of sessions applied. Hypothesis: 3 sessions of fESWT on equinus foot in stroke patients improve spasticity and functionality for longer term than 1 session of fESWT.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Age greater than 18 years old
Time from stroke (ischemic o hemorrhagic) onset of at least 6 months
Spastic equinus foot: triceps surae tone grade at least 1+ on the MAS score
Ability to walk alone with or without aids

Exclusion Criteria4

Fixed ankle joint contracture
Severe medical problems
Treatment of the affected leg with botulinum toxin in the las 6 months
Cognitive impairment

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEfESWT

Shock wave therapy will be applied with Duolith SD1 device (Storz Medical, Tagerwilen, Switzerland). Therapy will be administered in the gastrocnemius medial and lateral and in the soleus muscles. Parameters: 0.15mJ/mm2, 4-5 Hz, 1500 shoots/muscle.